Catalyst Wire Dossier Catalyst Wire Dossier

Oxbryta

voxelotor · Global Blood Therapeutics
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for Oxbryta, covering 2017-04-12 to 2026-08-21. Get the full timeline:

Most recent: EMA Suspended: Oxbryta (voxelotor) — Pfizer Europe MA EEIG

See pricing